BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Retina
,
Neocentromeres
,
Doxycycline
,
rs2230926
,
PBX1
,
calcium channel activity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
antigen i
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Pleiotropic consequences of metabolic stress for the major histocompatibility complex class II molec…
TLimmuno2: predicting MHC class II antigen immunogenicity through transfer learning.
Successful transatlantic bilateral hand transplant in a young female highly sensitized to HLA class …
MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells…
The association between chronic spontaneous urticaria and HLA class I and class II antigen
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Cancer/Testis Antigen Immunotherapy Phase I Study With 740-CTA Vaccinia Virus
Analysis of the Incidence of Expression of Tumor Antigens in Pathologically Proven Stage I, II and I…
Human Leukocyte Antigen (HLA) Class I Haplotype Mismatched Natural Killer Cell Infusions
Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cance…
Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ